BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6351647)

  • 1. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
    Papotti M; Eusebi V; Gugliotta P; Bussolati G
    Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation.
    Papotti M; Gugliotta P; Ghiringhello B; Bussolati G
    Histopathology; 1984 Nov; 8(6):963-75. PubMed ID: 6098550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions.
    Mosunjac MB; Lewis MM; Lawson D; Cohen C
    Diagn Cytopathol; 2000 Sep; 23(3):151-5. PubMed ID: 10945900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison.
    Eusebi V; Foschini MP; Betts CM; Gherardi G; Millis RR; Bussolati G; Azzopardi JG
    Am J Surg Pathol; 1993 Feb; 17(2):99-109. PubMed ID: 8422116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
    Hill CB; Yeh IT
    Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
    Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
    Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
    Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
    Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
    Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
    J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells.
    Raymond WA; Leong AS
    Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases.
    Alexiev B; Boschnakova Z; Prokopanov C
    Zentralbl Pathol; 1994 Jul; 140(2):129-34. PubMed ID: 7524651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.
    Tse GM; Tan PH; Ma TK; Gilks CB; Poon CS; Law BK
    J Clin Pathol; 2005 Nov; 58(11):1185-8. PubMed ID: 16254109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of papillary breast lesions.
    Troxell ML; Masek M; Sibley RK
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of breast papillary neoplasms: Community hospital experience.
    Vdovenko AA
    Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign versus malignant papillary neoplasms of the breast. Diagnostic clues in fine needle aspiration cytology.
    Dawson AE; Mulford DK
    Acta Cytol; 1994; 38(1):23-8. PubMed ID: 8291351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
    Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.